Form 4 filings across 1 company. Net figures count open-market buys and sales only. EDGAR profile ↗
Lifetime net: -$13.7K
Reported holding is the most recent post-transaction share count on a Table I row.
How quickly this filer reports. Section 16 allows two business days from the transaction.
All 4 filings we hold were filed within the two-business-day deadline.
Counted in business days from the transaction date, or the deemed execution date where the filing reports one, excluding weekends and federal holidays. How this is measured · All late filings
The 10 most recent Form 4 transactions.
| Jul 3 | DMRA | Damora Therapeutics, Inc. | MEXER | 680 | — | — | +36.7% | Open the original filing on SEC.gov |
| Mar 23 | DMRA | Damora Therapeutics, Inc. | AGRANT◆ | 250,000 | — | — | — | Open the original filing on SEC.gov |
| Jan 2 | DMRA | Damora Therapeutics, Inc. | MEXER◆ | 680 | — | — | — | Open the original filing on SEC.gov |
| Jan 2 | DMRA | Damora Therapeutics, Inc. | SSELL | 255 | $21.38 | $5.5K | -12.1% | Open the original filing on SEC.gov |
| Jan 2 | DMRA | Damora Therapeutics, Inc. | MEXER | 680 | — | — | +47.6% | Open the original filing on SEC.gov |
| Jul 3, 2025 | DMRA | Damora Therapeutics, Inc. | MEXER◆ | 680 | — | — | — | Open the original filing on SEC.gov |
| Jul 3, 2025 | DMRA | Damora Therapeutics, Inc. | SSELL | 260 | $3.39 | $881 | -15.4% | Open the original filing on SEC.gov |
| Jul 3, 2025 | DMRA | Damora Therapeutics, Inc. | MEXER | 680 | — | — | +67.4% | Open the original filing on SEC.gov |